Interim COVID-19 vaccination coverage in the EU/EEA during the 2023–24 season campaigns
In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023–24 season vaccination campaigns. This report presents an interim description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and January 2024.
Executive summary
During the reporting period, 24/30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one target group (people aged 60 years and above, people aged 80 years and above, healthcare workers, individuals with chronic conditions, pregnant women).
During this period, approximately 19.4 million people aged 60 years and above received one COVID-19 vaccine dose. Approximately 5.5 million people aged 80 years and above received one COVID-19 vaccine dose.
The median COVID-19 vaccination coverage among people aged 60 years and above was 11.1% (range: 0.01–65.8%), with high variation among countries. For people aged 80 years and above, the median coverage was 16.3% (range: 0.01–88.2%), with high variation among countries.
Among the 24 reporting countries, three countries reported a vaccination coverage ≥50% for the age group 60 years and above, while eight countries reported a vaccination coverage ≥50% for the age group 80 years and above.
Most of the approximately 22.7 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Comirnaty Omicron XBB.1.5 (Pfizer BioNTech) vaccine (around 22 million doses; 97% of the total doses administered).
These preliminary results must be interpreted with caution. A higher degree of data consolidation and data completeness is expected in the coming weeks and months.
Download
